As a value creation opportunity, the most significant digital transformation potential within life sciences lies within the R&D function. Here, technological modernization can enable organizations to bring their products to market far more rapidly and safely, and at a lower cost. The potential impact of a successfully executed digital transformation strategy on drug development is significant. But what does digital transformation within drug development actually look like?
This whitepaper explores digital transformation in the context of life sciences R&D, focusing specifically on the concept of a unified drug development technology platform. There are different philosophies underlying the strategies of various platform providers, and we will detail our view on the advantages and disadvantages of each approach.
Read the Whitepaper Today!